Inventor · disambiguated record
Babu J. Mavunkel
Also filed as: MAVUNKEL BABU · MAVUNKEL BABU J · MAVUNKEL BABU JOSEPH
24 granted patents·4 pending applications·849 citations·filing 1985–2007
97Inventor score
Top patents by PatentIndex Score
28 records- 0198US4889860AOximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonistsNOVA PHARM CORP·Filed 1987·Granted Dec 26, 1989·144 cites·22 claims
- 0298US4760069AOximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonistsNOVA PHARM CORP·Filed 1985·Granted Jul 26, 1988·135 cites·22 claims
- 0395US6867209B1Indole-type derivatives as inhibitors of p38 kinaseSCIOS INC·Filed 2000·Granted Mar 15, 2005·72 cites·62 claims
- 0494US6541477B2Inhibitors of p38-a kinaseSCIOS INC·Filed 2001·Granted Apr 1, 2003·59 cites·12 claims
- 0594US6448257B1Compounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 2000·Granted Sep 10, 2002·44 cites·17 claims
- 0693US6130235ACompounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 1998·Granted Oct 10, 2000·123 cites·39 claims
- 0789US6589954B1Compounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 1999·Granted Jul 8, 2003·78 cites·67 claims
- 0884US5204352ACompounds exhibiting anti-parasitic activity and a method for their useUS ARMY·Filed 1987·Granted Apr 20, 1993·25 cites·20 claims
- 0982US6696443B2Piperidine/piperazine-type inhibitors of p38 kinaseSCIOS INC·Filed 2001·Granted Feb 24, 2004·15 cites·54 claims
- 1081US6410540B1Inhibitors of p38-αkinaseSCIOS INC·Filed 1999·Granted Jun 25, 2002·53 cites·25 claims
- 1178US6864260B2Indole-type derivatives as inhibitors of p38 kinaseSCIOS INC·Filed 2002·Granted Mar 8, 2005·6 cites·27 claims
- 1277US7304048B2Indole-type derivatives as inhibitors of p38 kinaseSCIOS INC·Filed 2002·Granted Dec 4, 2007·7 cites·26 claims
- 1376US7214679B2Piperidine/piperazine-type inhibitors of p38 kinaseSCIOS INC·Filed 2004·Granted May 8, 2007·10 cites·20 claims
- 1472US7220763B2Indole-type derivatives as inhibitors of p38 kinaseSCIOS INC·Filed 2003·Granted May 22, 2007·5 cites·32 claims
- 1570US6340685B1Compounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 1999·Granted Jan 22, 2002·28 cites·12 claims
- 1665US2007161649A1INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASEMAVUNKEL BABU J·Filed 2007·Application pending·0 cites
- 1764US5817756APseudo- and non-peptide bradykinin receptor antagonistsSCIOS INC·Filed 1995·Granted Oct 6, 1998·31 cites·9 claims
- 1862US7238712B2Indole-type derivatives as inhibitors of p38 kinaseSCIOS INC·Filed 2002·Granted Jul 3, 2007·1 cites·30 claims
- 1962US7189726B2Benzofuran derivatives as inhibitors of p38-α kinaseSCIOS INC·Filed 2002·Granted Mar 13, 2007·1 cites·29 claims
- 2057US2007185112A1Piperidine/piperazine-type inhibitors of p38 kinaseMAVUNKEL BABU·Filed 2007·Application pending·0 cites
- 2156US7488744B2Indole-type derivatives as inhibitors of p38 kinaseSCIOS INC·Filed 2007·Granted Feb 10, 2009·0 cites·32 claims
- 2249US7189739B2Compounds and methods to treat cardiac failure and other disordersSCIOS INC·Filed 2002·Granted Mar 13, 2007·0 cites·38 claims
- 2343US2005288299A1Azaindole derivatives as inhibitors of p38 kinaseMAVUNKEL BABU J·Filed 2005·Application pending·0 cites
- 2440US2005065344A1Reagents for N-aminationFiled 2003·Application pending·0 cites
- 2538US5610142ABradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acidsSCIOS INC·Filed 1995·Granted Mar 11, 1997·4 cites·7 claims
- 2637US5552383ABradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefinsSCIOS NOVA INC·Filed 1993·Granted Sep 3, 1996·3 cites·9 claims
- 2737US5521158APseudopeptide bradykinin receptor antagonistsSCIOS NOVA INC·Filed 1992·Granted May 28, 1996·2 cites·14 claims
- 2834US5686565ABradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefinsSCIOS INC·Filed 1994·Granted Nov 11, 1997·3 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →